Tradestie Institutional Equity Comparison Engine

GRAL vs GH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GH Overall Edge

GH Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Guardant Health, Inc. Common Stock (GH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GRAL counters with relative strength in Valuation. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus GH at N/M Forward P/E and -39.4% operating margin (+36.1% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against GH sits in CONSOLIDATION (31st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRAL
GRAL 1.1x vs GH N/M Fwd P/E
Growth & Margin Winner GH
Op Margin -332.0% vs -39.4% ยท YoY +3.7% vs +36.1%
Momentum & Technical Winner GH
1Y +24.6% vs +53.0% ยท 52W Pos 51% vs 60%
Options & Structure Winner GH
BREAKDOWN (53rd %ile IV) vs CONSOLIDATION (31st %ile IV)
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
1M Return -10.36%
1Y Return +24.57%
Forward P/E 1.1x
Unified AI Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
GH NASDAQ
Guardant Health, Inc. Common Stock
Services-Medical Laboratories
$144.03
-5.06% 1D
Market Cap $20.5B
1M Return -9.19%
1Y Return +53.01%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 19.0 Fund 48.0 Flow 67.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRAL +24.57% GH +53.01% Spread: +26.09 pp (GH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period GRAL Revenue GH Revenue GRAL Op. Margin GH Op. Margin Margin Edge
FY2018 N/A $90M N/A -102.5% GH
FY2019 N/A $210M N/A -38.4% GH
FY2020 N/A $290M N/A -88.9% GH
FY2021 N/A $370M N/A -110.0% GH
FY2022 N/A $450M N/A -121.1% GH
FY2023 $90M $560M -1627.6% -100.1% GH
FY2024 $130M $740M -1743.0% -60.0% GH
FY2025 $150M $980M -382.0% -44.5% GH

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRAL (3) vs GH (7)
Institutional Metric GRAL GH Criterion Row Winner
Market Capitalization Scale $5.2B $20.5B Larger Scale GH
Trailing P/E Ratio Valuation 1.1x N/M Lower Multiple GRAL
Forward P/E Ratio Valuation 1.1x N/M Lower Multiple GRAL
Revenue Growth (YoY) Growth +3.7% +36.1% Higher Growth GH
Operating Margin (TTM) Profitability -332.0% -39.4% Higher Margin GH
Net Profit Margin Profitability -243.8% -37.9% Higher Margin GH
Return on Equity (ROE) Capital Efficiency -17.3% 0.0% Higher ROE GH
52-Week Range Position Momentum 51% ($42โ€“$166) 60% ($75โ€“$191) Stronger Trend GH
Beta / 30D Volatility Risk Regime 3.09ฮฒ ยท 99% Vol 1.32ฮฒ ยท 56% Vol Lower Realized Risk GH
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite GRAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRAL vs GH Buy Guide
GRAL BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GRAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GH CONSOLIDATION
96d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 31st %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRAL nor GH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.